Ranbaxy Laboratories Ltd has said it will take “stern action” against the employees responsible for a recent import ban by the US drugs regulator on its Toansa plant in Punjab. Industry sources say the management might fire 10 employees involved in the production process at the Toansa plant for failing to maintain quality at the facility. However, the company refused to comment on what kind of action would be taken. The US Food and Drug Administration on January 24 issued an import alert against the Toansa plant, banning all products made at this facility from entering the US market.
Read the Hindu Business Line news report here.